Charleston, SC -- (SBWIRE) -- 08/28/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: AMR Corporation (OTCMKTS:AAMRQ), Invivo Therapeutics Holdings Corp (OTCBB:NVIV), Eastman Kodak Company (OTCMKTS:EKDKQ), Nutra Pharma Corp. (OTCMKTS:NPHC)
AMR Corporation (OTCMKTS:AAMRQ) opened at the price of $3.10 along with 2.20 million shares outstanding and touched its highest price of the day at $3.10 recently, the stock is trading at the price of $3.05 by scoring -1.93% at time 10:02AM.
The stock’s previous performance of one month showed that it lost almost -46.33%. In previous 3 months it scored/ dropped -47.07%. During its current trading session stocks gained a volume of 2.20 million shares up-till now which is lower than its average volume of 13.81 million shares. AMR Corporation operates in the airline industry. The company, through its subsidiary, American Airlines, Inc., provides scheduled jet service to approximately 160 destinations throughout North America, the Caribbean, Latin America, Europe, and Asia; and operates as a scheduled air freight carrier, which provides a range of freight and mail services to shippers.
Has AAMRQ Found The Bottom and Ready To Move Up? Find Out Here
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) stock recently hit highest price at $1.93, starting its day trade with a price of $1.92 and reported a decrease of -27.54%, its most recent trading price was $1.52 at 10:04 AM. 52 week price range of the company is $1.25 - $6.20 while today till 10:05AM its minimum price was $1.46. Invivo Therapeutics recently added a volume of 1.20 million shares versus its average volume of 46,372 shares.
Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Why Should Investors Buy NVIV After the Recent Fall? Just Go Here and Find Out
Eastman Kodak Company (OTCMKTS:EKDKQ) remained among bears of the day during early hours of trading, as it went down -4.32% recently. Beta value of the stock remained at 1.80 points while its earning per share was -$2.18.
During last 5 day’s it lost -28.41%, while its last one month’s performance stands at -47.05%. The company’s traded volume is 7.68 million shares as compares to its average volume of 13.49 million shares. Eastman Kodak Company engages in commercial imaging business. It operates through three segments: the Graphics, Entertainment and Commercial Films (GECF); the Digital Printing and Enterprise (DP&E); and the Personalized and Document Imaging (P&DI).
Will EKDKQ Get Buyers Even After The Recent Rally? Find Out Here
Nutra Pharma Corp. (OTCMKTS:NPHC) is trading with a fall of -27.60% along with the exchange price of $0.0160 up till now while its today’s introductory price for today was $0.02.
Company’s 6 month’s performance gave a bright outlook as it gained +128.57% while in its last 5 days its performance remained green with an improvement of +81.82%. Today till 10:08AM its minimum price was $0.01. Nutra Pharma recently added a volume of 14.68 million shares versus its average volume of 4.55 million shares. Nutra Pharma Corporation, a biotechnology company, engages in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases.
Has NPHC Found The Bottom And Ready To Gain Momentum? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)